No, Took half out when I learned Avtar Dhillon was involved and took the rest out when DR. KSS bailed. Check out the product Veti-Gel developed by 17 year old Joe Landolina. This product is already approved and in use. A 17 year old can invent the same thing as ARTH and get it manufactured and approved and on the market but this team of boneheads at ARTH cannot even get their glorified bandaid through the process. They should have done their research to know what was necessary to get FDA approval before applying and failing. They have not followed through on a single goal and have never met a projected timeline. There are more products in the pipeline by other medical inventors that are far better than ARTHs that will be approved before ARTHs thus making their product worthless if they ever do manufacture it (which they have stated they have no plan for). There technology is no longer state of the art. They missed the boat to be the go to hemotological gurus, but I seriously doubt they care because it was the stock scam that is their real gig anyhow.
And just like the Avtar Dhillon playbook, they make a benign (pump) announcement after months of no communication on June 26 sending the stock to .65 and then announce dilution on June 29 sending the stock back to .40. I only come to this board while I'm on this site to see just how many times they can milk this pig. Avtar Dhillon is an expert in stock scams and he has perfected the game. It seems he can draw investors in for longer and longer periods until he moves on to the next one, but be careful because he recently got on another penny stock board so this isn't his only ride so when this crashes he won't care. He'll still be laughing all the way to the bank and will have learned another lesson. The question is will the gamblers (I mean investors) of ARTH learn?
News 
Market Data 
Discover 
